Speaker

Jacob Jeppesen

Chief Scientific Officer & Head of Research & Development, Alveus Therapeutics

Jacob Jeppesen, Chief Scientific Officer & Head of Research & Development, Alveus Therapeutics, is speaking at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Panel & Audience Discussion: Evaluating Oral, Injectable & DNA Delivery Methods to Align Modality Selection with Clinical Performance & Commercial Scale”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Obesity & Weight Loss Drug Development Summit Europe
28–29 Oct 2026Munich, Germany
- PanelPanel & Audience Discussion: Evaluating Oral, Injectable & DNA Delivery Methods to Align Modality Selection with Clinical Performance & Commercial Scale
- SpeakerTackling Tolerability in Obesity Drug Development

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jacob Jeppesen, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].